|
1.
|
Shiga K, Tateda M, Katagiri K, et al:
Distinct feature of second primary malignancies in head and neck
cancer patients in Japan. Tohoku J Exp Med. 225:5–12. 2011.
|
|
2.
|
Zhu H, Zhang Y, Ye G, Li Z, Zhou P and
Huang C: In vivo and in vitro antiviral activities of
calycosin-7-O-beta-D-glucopyrano-side against coxsackie virus B3.
Biol Pharm Bull. 32:68–73. 2009.
|
|
3.
|
Kubo M, Kimura Y, Odani T, Tani T and
Namba K: Studies on Scutellaria radix. Part II: The antibacterial
substance. Planta Med. 43:194–201. 1981.
|
|
4.
|
Huang YL, Kou JP, Ma L, Song JX and Yu BY:
Possible mechanism of the anti-inflammatory activity of ruscogenin:
role of intercellular adhesion molecule-1 and nuclear
factor-kappaB. J Pharmacol Sci. 108:198–205. 2008.
|
|
5.
|
Tan W, Lu J, Huang M, et al: Anti-cancer
natural products isolated from Chinese medicinal herbs. Chin Med.
6:272011.
|
|
6.
|
Huang RL, Chen CC, Huang HL, et al:
Anti-hepatitis B virus effects of wogonin isolated from
Scutellaria baicalensis. Planta Med. 66:694–698. 2000.
|
|
7.
|
Huang WH, Lee AR and Yang CH:
Antioxidative and anti-inflammatory activities of
polyhydroxyflavonoids of Scutellaria baicalensis GEORGI.
Biosci Biotechnol Biochem. 70:2371–2380. 2006.
|
|
8.
|
Fas SC, Baumann S, Zhu JY, et al: Wogonin
sensitizes resistant malignant cells to TNFalpha- and TRAIL-induced
apoptosis. Blood. 108:3700–3706. 2006.
|
|
9.
|
Liu JJ, Huang TS, Cheng WF and Lu FJ:
Baicalein and baicalin are potent inhibitors of angiogenesis:
inhibition of endothelial cell proliferation, migration and
differentiation. Int J Cancer. 106:559–565. 2003.
|
|
10.
|
Wang W, Guo QL, You QD, et al: The
anticancer activities of wogonin in murine sarcoma S180 both in
vitro and in vivo. Biol Pharm Bull. 29:1132–1137. 2006.
|
|
11.
|
Lu N, Gao Y, Ling Y, et al: Wogonin
suppresses tumor growth in vivo and VEGF-induced angiogenesis
through inhibiting tyrosine phosphorylation of VEGFR2. Life Sci.
82:956–963. 2008.
|
|
12.
|
Li C, Yazawa K, Kondo S, Mukudai Y, Sato
D, Kurihara Y, Kamatani T and Shintani S: The root bark of
Paeonia moutan is a potential anticancer agent in human oral
squamous cell carcinoma cells. Anticancer Res. 32:2625–2630.
2012.
|
|
13.
|
Nagumo T, Takaoka S, Yoshiba S, et al:
Antitumor activity of suberoylanilide hydroxamic acid against human
oral squamous cell carcinoma cell lines in vitro and in vivo. Oral
Oncol. 45:766–770. 2009.
|
|
14.
|
Kondo S, Kubota S, Shimo T, et al:
Connective tissue growth factor increased by hypoxia may initiate
angiogenesis in collaboration with matrix metalloproteinases.
Carcinogenesis. 23:769–776. 2002.
|
|
15.
|
Yasuda Y, Kondo S, Nagumo T, et al:
Anti-tumor activity of dehydroxymethylepoxyquinomicin against human
oral squamous cell carcinoma cell lines in vitro and in vivo. Oral
Oncol. 47:334–339. 2011.
|
|
16.
|
Kondo S, Tanaka N, Kubota S, et al: Novel
angiogenic inhibitor DN-9693 that inhibits post-transcriptional
induction of connective tissue growth factor (CTGF/CCN2) by
vascular endothelial growth factor in human endothelial cells. Mol
Cancer Ther. 5:129–137. 2006.
|
|
17.
|
Zhang DY, Wu J, Ye F, et al: Inhibition of
cancer cell proliferation and prostaglandin E2 synthesis by
Scutellaria baicalensis. Cancer Res. 63:4037–4043. 2003.
|
|
18.
|
Scheck AC, Perry K, Hank NC and Clark WD:
Anticancer activity of extracts derived from the mature roots of
Scutellaria baicalensis on human malignant brain tumor
cells. BMC Complement Altern Med. 6:272006.
|
|
19.
|
Wang CZ, Li XL, Wang QF, Mehendale SR and
Yuan CS: Selective fraction of Scutellaria baicalensis and
its chemopreventive effects on MCF-7 human breast cancer cells.
Phytomedicine. 17:63–68. 2010.
|
|
20.
|
Bonham M, Posakony J, Coleman I,
Montgomery B, Simon J and Nelson PS: Characterization of chemical
constituents in Scutellaria baicalensis with antiandrogenic
and growth-inhibitory activities toward prostate carcinoma. Clin
Cancer Res. 11:3905–3914. 2005.
|
|
21.
|
Parajuli P, Joshee N, Rimando AM, Mittal S
and Yadav AK: In vitro antitumor mechanisms of various
Scutellaria extracts and constituent flavonoids. Planta Med.
75:41–48. 2009.
|
|
22.
|
Tayarani Najaran Z, Emami SA, Asili J,
Mirzaei A and Mousavi SH: Analyzing cytotoxic and apoptogenic
properties of Scutellaria litwinowii root extract on cancer
cell lines. Evid Based Complement Alternat Med.
2011:1606822011.
|
|
23.
|
Hsu CH, Hwang KC, Chao CL, et al: An
evaluation of the additive effect of natural herbal medicine on
SARS or SARS-like infectious diseases in 2003: A randomized,
double-blind, and controlled pilot study. Evid Based Complement
Alternat Med. 5:355–362. 2008.
|
|
24.
|
Adams LS, Seeram NP, Hardy ML, Carpenter C
and Heber D: Analysis of the interactions of botanical extract
combinations against the viability of prostate cancer cell lines.
Evid Based Complement Alternat Med. 3:117–124. 2006.
|
|
25.
|
Lin YT, Yang JS, Lin HJ, et al: Baicalein
induces apoptosis in SCC-4 human tongue cancer cells via a
Ca2+-dependent mitochondrial pathway. In Vivo.
21:1053–1058. 2007.
|
|
26.
|
Li-Weber M: New therapeutic aspects of
flavones: the anti-cancer properties of Scutellaria and its
main active constituents wogonin, baicalein and baicalin. Cancer
Treat Rev. 35:57–68. 2009.
|
|
27.
|
Liao HL and Hu MK: Synthesis and
anticancer activities of 5, 6, 7-trimethylbaicalein derivatives.
Chem Pharm Bull. 52:1162–1165. 2004.
|
